Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

Procurement of Sonosite LX Ultrasound System (Notice of Intent to Sole Source)

Active
NOI-26-008281Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → National Institutes Of Health - CcView Agency

NAICS

334510 - Electromedical and Electrotherapeutic Apparatus ManufacturingView NAICS

Place of Performance

MD, 20814, USA

Set-Aside

NONE

Documents

(1)

1.+Statement+of+Need_PICU+Fujifilm+Ultrasound.1.docx

DOCX

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhasePresolicitation
Posted

Presolicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health - Cc
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health - Cc
View Agency Profile
Office AddressBETHESDA, MD, 20892, USA
Contacts

Full Description

Show more

The National Institutes of Health (NIH) Clinical Center requires the acquisition of a FUJIFILM Sonosite LX Point-of-Care Ultrasound (POCUS) System with multiple transducers to support pediatric critical care imaging. The system includes advanced diagnostic imaging capabilities, Color and Spectral Doppler, Tissue Harmonic Imaging, DICOM connectivity, wireless networking, integrated educational resources, manufacturer installation and training, and a five-year comprehensive warranty. The acquisition also includes specialty transducers to support cardiac, abdominal, pulmonary, vascular access, musculoskeletal, neonatal, and pediatric imaging applications.


Justification:


The Sonosite LX will provide clinicians with high-quality, real-time bedside imaging necessary for the care of critically ill pediatric patients in the Pediatric Intensive Care Unit (PICU). The system supports rapid diagnosis and ultrasound-guided procedures, including vascular access, cardiac assessments, pulmonary evaluations, abdominal imaging, and other point-of-care applications. Its portability, exceptional image quality, intuitive touchscreen workflow, advanced needle visualization technology, and comprehensive imaging capabilities enable timely clinical decision-making, improve procedural success, reduce complications, and enhance patient safety. The inclusion of multiple transducers allows a single platform to support a broad range of pediatric and critical care examinations, maximizing clinical utility while minimizing equipment redundancy. The five-year manufacturer warranty and onsite clinical training further ensure long-term reliability and successful implementation.


FUJIFILM Sonosite is a recognized industry leader in point-of-care ultrasound technology with extensive experience supporting hospitals and critical care environments. The vendor offers the complete Sonosite LX platform, manufacturer-certified installation, clinical education, technical support, and a comprehensive five-year warranty for both the ultrasound system and transducers. The proposed equipment is available through an existing federal contract, ensuring compliance with federal procurement requirements while providing access to factory-authorized service, software updates, replacement components, and ongoing technical support. As the original equipment manufacturer, FUJIFILM Sonosite is uniquely qualified to provide the equipment, warranty coverage, training, and lifecycle support necessary to maintain safe and reliable operation in the NIH Clinical Center's Pediatric Intensive Care Unit. FUJIFILM is the sole source manufacturer and direct distributor for new Sonosite point-of-care ultrasound equipment in the U.S. Therefore, no re-seller or third-party distributor will be able to offer a lower price on new Sonosite equipment.



Place of Performance or Delivery:



The Period of Performance is:


09/28/2026 – 09/27/2027


Delivery within 30 days of award, or as otherwise mutually agreed to



Place of Performance: NIH Clinical Center in Bethesda, MD



The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.  All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-26-008281) by 5:00 PM eastern standard time on 09/27/2026 to: lu-chang.lu@nih.gov


All responses received by the closing date of this synopsis will be considered by the Government.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

Similar Contracts

Same NAICS industry code

NAICS: 334510
New
Federal
Electro-Therapeutic Modalities for Pain Management (ETMPM) - Transcutaneous Electrical Nerve Stimulation (TENS) Procurement Program
Solicitation # 36C79126R0011
The Department of Veterans Affairs is soliciting proposals under Solicitation 36C79126R0011 to establish multiple Firm-Fixed-Price, Indefinite Delivery/Indefinite Quantity (IDIQ) base contracts for the Electro-Therapeutic Modalities for Pain Management (ETMPM) program. This procurement focuses on FDA-cleared devices and accessories, including Transcutaneous Electrical Nerve Stimulation (TENS), Interferential Current Therapy (IFC), Short-Wave Diathermy (SWD), and portable Neuromodulation systems. The contract consists of a base year and four option years, with an aggregate ceiling of 500 million dollars. All products must meet universal minimum technical requirements and be delivered to the Denver Logistics Service within 30 calendar days of order issuance. The government utilizes a tiered set-aside evaluation approach prioritizing Service-Disabled Veteran-Owned Small Businesses (Tier 1), followed by Veteran-Owned Small Businesses (Tier 2), other small businesses (Tier 3), and large businesses (Tier 4). Award decisions are made on a per-CLIN/SLIN basis. CLINs X001 through X004 are evaluated using the Lowest Price Technically Acceptable (LPTA) method, while CLIN X005 is evaluated via a Best-Value Tradeoff, weighting technical factors at 60 percent, price at 25 percent, and past performance at 15 percent. Proposals are due by October 19, 2026, at 3:00 PM CDT. A responsive submission must include a properly executed SF 1449, a technical capability statement, FDA clearance letters, three past performance documents, and product samples shipped to the Denver Logistics Service. Mandatory certifications include the Buy American Certificate (Attachment 0004) and the Trade Agreements Certificate (Attachment 0005), the latter of which is a material condition for responsiveness for all offerors. Non-manufacturers must also provide OEM-issued authorized distributor letters.
Commodities & Services Acquisition Service (36C791)

POSTED

about 18 hours ago

DEADLINE

in 26 days
View Details
NAICS: 334510
New
Federal
Laser Beam Measurement System
Solicitation # N0018926QB135
Solicitation N0018926QB135, issued by NAVSUP Fleet Logistics Center Norfolk, seeks a Firm Fixed Price contract for a custom-made laser beam measurement system to support research on biological tissue damage by the Directed Energy Health Effects group. The system must be compatible with a Coherent 10kW laser and include a beam expander with a collimator capable of reaching a 4cm beam size, a power sensor, a beam profiler system, and a beam dump. The contractor is responsible for providing all necessary mounting plates, adapters, and components for assembly, as well as handling shipping and installation. The equipment will be delivered FOB Destination to the Naval Medical Research Unit in Fort Sam Houston, Texas. The government will award the contract based primarily on price, though it may consider capability statements and past performance to ensure the best value. Offerors must provide a capability statement and complete annual representations and certifications via the System for Award Management. The contract includes strict requirements for Item Unique Identification (IUID) for assets valued at $5,000 or more, adhering to MIL-STD-130 and MIL-STD-129 standards. Payment will be processed electronically through the Wide Area WorkFlow system. The final deadline for the receipt of offers is September 25, 2026, at 12:00 PM.
Navsup Flt Logistics Ctr Norfolk

POSTED

about 18 hours ago

DEADLINE

in 1 day
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health - Cc

Same awarding agency

NAICS: 325412
New
Federal
Piflufolastat F-18 injection drugs (Pylarify) from Lantheus (Notice of Intent to sole source)
Solicitation # NOI-27-000004
The National Institutes of Health Clinical Center intends to award a sole-source contract to Progenics Pharmaceuticals Inc., a Lantheus company, for the procurement of Piflufolastat F-18 injection (Pylarify). This FDA-approved radiopharmaceutical is used for the scintigraphic localization of prostate-specific membrane antigen positive lesions in men with prostate cancer. Due to the rapid radiation decay and short half-lives of the drug, it must be compounded, calibrated, and delivered as patient-ready unit doses on demand to the NIH Clinical Center Nuclear Pharmacy Facility in Bethesda, Maryland. The procurement is justified under FAR 8.405-6(b) and 41 U.S.C. 1901(a)(1) because Progenics Pharmaceuticals is the sole authorized provider and intellectual property owner capable of meeting the highly specialized quality and regulatory requirements of the FDA and the U.S. Nuclear Regulatory Commission. The contract is structured as an Indefinite Delivery/Indefinite Quantity requirement for 150 to 230 injections and four unused dose fees. The period of performance consists of a base year from October 1, 2026, to September 30, 2027, with four subsequent option years extending through September 30, 2031. The award will be made using GSA Contract 36F79719D0170 and includes an economic price adjustment clause per FAR 52.216-2 for 2026 pricing. Performance is measured by the accuracy of delivered doses, the absence of contamination, and strict adherence to federal regulatory standards.
Pharmaceutical Preparation Manufacturing

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 513210
New
Federal
Cloverleaf Security Server maintenance and support - Bethesda Site (Notice of Intent to sole source)
Solicitation # NOI-26-008015
The National Institutes of Health Clinical Center, Department of Clinical Research Informatics, intends to negotiate a sole source contract with Infor LLC for maintenance and support of the Cloverleaf Security Server at the Bethesda, Maryland site. This mission critical system provides essential encryption for the HL7 interface engine, which serves as the primary link between the Clinical Research Information System and various ancillary systems, including laboratory and radiology information systems. Because the software is proprietary to Infor and critical for the safe delivery of patient care and the protection of personally identifiable information, the government has determined that Infor is the only responsible source capable of providing the necessary maintenance and source code revisions. The period of performance is scheduled from September 26, 2026, to September 25, 2027. The scope of work includes the provision of no-cost application updates, email notifications for updates, 24x7 remote telephone technical support, and access to a 24x7 web knowledge base. Additionally, the contractor must maintain an established escalation process for critical issues. All deliverables must be marked with the date, offeror name, and task order details, with final inspection and acceptance conducted by the Contracting Officer's Representative at the NIH facility in Bethesda.
Software Publishers

POSTED

3 days ago

DEADLINE

in about 15 hours
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS